STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
This study has been completed.
Study NCT00088088
Information provided by Synta Pharmaceuticals Corp.
First Received on July 20, 2004.
Last Updated on December 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
